Recurrent Pancreatic Carcinoma Active Not Recruiting Phase 2 Trials for Dabrafenib (DB08912)

Also known as: Pancreatic carcinoma recurrent / Pancreas carcinoma recurrent / Pancreatic cancer recurrent